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Abstract
           
Objectives:  Brain natriuretic peptide (BNP) was a marker for heart failure and cardiac wall 
tension. We analysed the trend of BNP after predischarge testing in order to get non-invasive 
details about the cardiac stress during predischarge testing.                                           
Methods: 4-5 days after ICD implant we measured BNP, myoglobin, cardiac troponin I and 
creatine kinase in 20 patients before and 1, 5, 10, 20, 40, 60, 80, 100, 120 minutes and at the 
next day after predischarge testing. We evaluated actual values and percentage alterations of 
BNP.  
Results: BNP significantly increased with a maximum after 5 minutes (804.0 ± 803.4 vs. 475.7 
± 629.5 pg/ml, P < 0.0001) and in terms of the percentage values (100 vs. 199.4 ± 61.4 %, P < 
0.0001) compared with baseline BNP. BNP decreased after that with the last significantly 
increased BNP value after 20 minutes (540.2 ± 604.9 vs. 475.7 ± 629.5 pg/ml, P = 0.017). We 
excluded a cardiac necrosis during predischarge testing because of similar values of myoglobin, 
cardiac troponin I and creatine kinase during the 2-hour follow-up.                                 
Conclusions: Our data showed a great increase with a doubling of BNP after 5 minutes as a 
result of induced ventricular fibrillation during predischarge test. This increase was not 
generated by myocardial necrosis but rather caused by an acute cardiac failure as a consequence 
of induced ventricular fibrillation in predischarge testing.   
Key Words: Predischarge ICD Test, Brain Natriuretic Peptide 
Introduction
            Clinical trials showed the efficacy of implantable cardioverter defibrillators (ICDs) for 
prevention of sudden cardiac death1,2. After the implantation of an ICD predischarge testing was 
performed to ensure the intraoperatively   detected   defibrillation   threshold3,4.   Ventricular 
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fibrillation was induced and terminated with shock by the ICD for predischarge testing. 
Ventricular fibrillation caused a cardiac low output5.                                                     
               Brain natriuretic peptide (BNP) is a powerful neurohormonal predictor of the left 
ventricular function and prognosis and could reflect the pulmonary capillary wedge pressure6-9. 
In addition BNP had a half-life of 20 minutes and is produced in response to ventricular wall 
tension. Messenger ribonucleic acid is rapidly released in response to wall tension9,10. Prior 
studies showed an increase of atrial natriuretic peptide without evaluation of a further follow-up 
of atrial natriuretic peptide11,12. But the further trend of BNP was unclear which could comprise 
important   information   for   post-shock   pacing.                                                          
            Hence, BNP is an appropriate parameter for the evaluation of cardiac stress during 
predischarge testing because of its physiology and timing release. Thus the purpose of our 
prospective study was to evaluate the trend of BNP after predischarge testing 4-5 days after ICD 
implant   in   an   experimental   study.                                                                
Methods
Study   Population   and   ICD   Systems                                                                
            We included 20 consecutive patients (15 males, 5 females) with different ICDs during 
predischarge testing in an experimental study. All were patients admitted electively in our 
hospital for implantation of an ICD. Patients with a serum creatinine ≥ 1.5 mg/dl were excluded 
because of possible influence of BNP values13. The transvenous endocardial leads were inserted 
under fluoroscopy in all patients via the cephalic or subclavian vein and the ICD was positioned 
in   sub   pectoral   position.                                                          
Study   Design                                                                              
            The BNP values (Triage Meter Plus®, Biosite GmbH, Willich, Germany) were measured 
directly before (baseline) and 1, 5, 10 and 20 minutes after predischarge testing. Furthermore 
BNP was measured for five half-life's (40, 60, 80, 100, 120 minutes) after predischarge testing 
and at the next day in the morning.                                                                                 
            In addition myoglobin, cardiac troponin I and creatine kinase were also measured with 
Triage Meter Plus®. The normal values were 0 - 4.3 ng/ml for creatine kinase (detection limit 
1.0 ng/ml), 0 - 107 ng/ml for myoglobin (detection limit 5 ng/ml) and 0 - 0.4 ng/ml for troponin 
I (detection limit 0.05 ng/ml). Blood was taken from a peripheral intravenous catheter.
            The local medical ethics committee approved the study protocol and all patients gave 
written, informed consent before entering the study.                                                                   
Predischarge testing                                                                                                       
            Short-term anaesthesia was performed with propofol and midazolam in all patients. The 
patients were fasting and received no intravenous diuretic in the morning. Ventricular fibrillation 
was induced by T wave shock. The duration of ventricular fibrillation was defined as interval 
between the induction of ventricular fibrillation and the termination of ventricular fibrillation 
with a biphasic shock of the ICD. The programmed post shock pacing was not changed. All 
patients with CRT were tested in paced rhythm in biventricular mode. Patients with single or 
dual chamber ICD were tested with intrinsic QRS. We included only patients who were 
successfully defibrillated with the first initial delivered shock energy in order to consist the same 
condition for all patients in our study.
Statistics
            All data are presented as mean values ± standard deviation. Datasets were tested for 
normal distribution. The real BNP values showed a skew distribution. Here, the Mann-Whitney 
U test was employed. We calculated the percentage alterations of BNP for the reduction of 
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standard deviation of the measurements because of the high standard deviation of real BNP 
values. The BNP value before predischarge testing was equated with 100% for evaluation of 
percentage alterations. For comparisons of the follow-up myoglobin, BNP (%),  cardiac troponin 
I and creatine kinase the two-sided Friedman ANOVA test was performed. A measure of the 
linear association between two variables was evaluated using Pearson's correlation coefficient; 
all statistical tests were two-tailed. A multivariate Cox regression analysis was performed on 
variables regarded as significant predictors (P < 0.1) with a univariate analysis. For all variables 
with at least a moderate level of association we estimated the individual odds ratios with 
confidence intervals. A P value < 0.05 was considered statistically significant. The statistical 
package that we used was SPSS 12.0 for Windows.                                                                     
Results
            The demographic data are presented in Table 1. No patient was excluded from our study 
because in all patients ventricular fibrillation was induced by the first T wave shock and 
ventricular fibrillation was terminated with the first biphasic shock of the ICD. All patients were 
implanted  an ICD for primary prevention.  Fourteen  patients  (70%) were in NYHA III 
classification. Eleven patients had sinus rhythm, which was the predominant rhythm; six patients 
showed paroxysmal atrial fibrillation and three patients had permanent atrial fibrillation. 
Thirteen patients had a bundle brunch block in the ECG. Eleven of them (85%) had a left bundle 
brunch block and two of them (15%) had a right bundle brunch block. The mean QRS duration 
in the ECG was 138.4 ± 27.3 msec (intrinsic QRS in all patients). The mean serum creatinine 
was 1.02 ± 0.18 mg/dl. 
Table 1: Patients characteristics
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Predischarge   testing                                                            
            The results of predischarge testing are shown in Table 2. Ventricular fibrillation was 
induced in all patients at the first attempt of T wave shock and successfully defibrillated with the 
initial   delivered   shock   energy.                                                      
Enzyme   and   cardiac   markers   trend   after   predischarge   testing                                
            The mean baseline BNP value was 475.7 ± 629.5 pg/ml (range 43.8 – 2860 pg/ml). The 
BNP five minutes after predischarge testing was significantly higher (804.0 ± 803.4 vs. 475.7 ± 
629.5 pg/ml, P < 0.0001) than baseline BNP (Figure 1). The last significantly increased BNP 
value was measured 20 minutes (540.2 ± 604.9 vs. 475.7 ± 629.5 pg/ml, P = 0.017) after 
predischarge testing (Table 2). 
Figure 1: BNP trend in real values
Table 2: Results of predischarge testing 
            BNP was doubled after 5 minutes in terms of the percentage values (100 vs. 199.4 ± 61.4 
%, P < 0.0001). We also observed an increase of BNP in terms of the percentage values 
followed   by   a   consistent   decrease   of   BNP   compared   with   baseline   BNP   (Figure   2). 
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Figure 2: BNP trend in percentage values
            The cardiac markers namely myoglobin, cardiac troponin I and creatine kinase showed 
no significant increases after predischarge testing (Table 3). 
Table 3: Values of BNP, myoglobin, cardiac troponin I and creatine kinase
Abbreviation: PT = predischarge testing, ¹ = P = 0.009 in comparison to BNP before predischarge testing, ² = P < 
0.0001 in comparison to BNP before predischarge testing, ³ = P = 0.001 in comparison to BNP before 
predischarge testing, † = P = 0.017 in comparison to BNP before predischarge testing, $ = P = 0.0003 in 
comparison to BNP before predischarge testing, ¶ = P = 0.002 in comparison to BNP before predischarge testing
Correlation
            We did not observe any correlation (P > 0.1 for all parameters) or an independent 
predictor (P > 0.3 for all parameters) for the rise or the trend of BNP, myoglobin, cardiac 
troponin I, creatine kinase, cycle length of ventricular fibrillation, duration of ventricular 
fibrillation, defibrillation threshold, serum creatinine and left ventricular ejection fraction.  
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Discussion
            In our study we observed an increase of BNP after predischarge testing with a doubling 
of BNP values after five minutes. After reaching the maximum we found a consistent decrease 
of BNP with the last significantly increased BNP value after 20 minutes. A myocardial necrosis 
could be excluded by similar values of myoglobin, cardiac troponin I and creatine kinase. We 
did   not   find   a   correlation   between   the   BNP   trend   and   other   parameters.  
Atrial natriuretic peptide and ventricular tachycardia                                                   
            In the present study we documented a short-term increase of BNP after predischarge 
testing with a maximum after 5 minutes followed by a consistent decrease of BNP. As far as we 
know this is the first study, in which a trend of BNP for two hours after predischarge testing was 
examined.
            Unlike prior studies11,12, our study definitively shows a trend of BNP for a period of 120 
minutes. Previous investigators reported that ventricular tachycardia caused an increase of atrial 
natriuretic peptide during electrophysiological study11,12. Fromer et al.11 examined 11 patients 
and observed an increase of atrial natriuretic peptide (93 vs. 234 pg/ml, P < 0.05) 30 seconds 
after the induction of the ventricular tachycardia. The blood samples were taken from the right 
atrium11. Cohen et al.12 examined 8 patients and also found an increase of atrial natriuretic 
peptide (95 vs. 140 pg/ml, P < 0.008) during an induced ventricular tachycardia and 30 seconds 
after the termination of the induced ventricular tachycardia (95 v. 145 pg/ml, P < 0.001). Cohen 
et al.12  excluded a correlation between the atrial natriuretic peptide and the cycle length of 
ventricular tachycardia. The blood samples were taken from the right ventricle in their study12. 
Thus ventricular tachycardia caused a short-term increase of BNP and atrial natriuretic peptide 
as a result of atrial and ventricle wall tension10.                                                                   
Cardiac behaviour during predischarge testing                                                           
            Ventricular fibrillation causes a hypotension, a reduction of the left ventricular ejection 
fraction as well as a dilation of the right and left ventricle14-16. The cardiac stress during 
ventricular tachyarrhythmia was observed on the one hand with an increase of the left 
ventricular end-diastolic pressure17,18 and on the other hand with an increase of BNP and atrial 
natriuretic peptide11,12. The increase of BNP or atrial natriuretic peptide was slightly temporally 
delayed because messenger ribonucleic acid is rapidly released in response to wall tension 11,12. 
This was the possible reason for the consistent increase and maximum of the BNP level 5 
minutes   after   predischarge   testing.                                                              
            Although our enzyme data excluded a myocardial necrosis during predischarge ICD test, 
we could not exclude a contributory role of acute ischemia during ventricular fibrillation 
induction in accounting for the transient rise in BNP because of high detection limit of 0.05 
ng/ml   for   troponin   I.                                                                              
  
Enzyme trend after predischarge testing                                                                 
            During the two hour follow-up we found similar values of myoglobin, cardiac troponin I 
and creatine kinase. An increase of myoglobin, cardiac troponin I and creatine kinase was 
observed in other studies19-21. There were important differences between these studies19-21 and 
our study. Firstly, they examined patients during the implantation of an ICD. The patients 
received at least two shocks for the evaluation of the defibrillation threshold and in some cases 
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an external cardioversion. Therefore a higher cumulative energy was needed for defibrillation 
with an energy depending increase of troponin I. In contrast to those studies our patients 
received only one internal shock for predischarge testing. We did not find an increase of cardiac 
enzymes, which was likely related to the low energy for predischarge testing in contrast to 
multiple shocks during ICD implantation. Secondly, ventricular fibrillation had to be induced 
several times during the ICD implantation as a result of multiple validations of the defibrillation 
threshold. Through this the time of cumulative ventricular fibrillation time increased which 
could cause a cardiac ischemia19-21. Thirdly, one or two leads were implanted during the surgery, 
which caused a traumatic injury of the heart. During the predischarge testing these leads were 
ingrown for at least four days. Thus we excluded a traumatic injury of the heart during 
predischarge testing in contrast to the ICD implantation. A further reason for similar values of 
myoglobin, cardiac troponin I and creatine kinase could be related to the sensitivity of the test 
and   the   time   frame   of   our   measurements.                                                            
Limitation
            The blood samples were taken from a peripheral intravenous catheter in our study. 
Therefore we could not exclude a dilution of our BNP values in contrast to the studies of Fromer 
et al11 and Cohen et al.12 Their blood samples were taken from inside the heart. BNP values 
showed   intra-individual   biological   variations,   which   could   influence   our   results22.   The 
heterogeneous post-shock pacing might have influenced the BNP trend in our study. In other 
studies an increase of myoglobin, cardiac troponin I and creatine kinase was detected two hours 
after the defibrillation threshold validation19-21. Thus we could not exclude cardiac ischemia in 
the further follow-up or between the interval of 120 minutes and the next day. We did not find 
troponin I values above the detection limit of 0.05 ng/ml. Thus we could not exclude a 
significant alteration of troponin I below this detection limit.                                
Conclusions
            A doubling of BNP was detected after 5 minutes of predischarge testing as a result of 
induced ventricular fibrillation. This increase was generated by ventricular fibrillation and is not 
caused by myocardial necrosis. Through this a strong cardiac wall tension was detected 
indirectly with BNP as a result of induced ventricular fibrillation. But it is unclear how far a 
modified post-shock pacing can alter the trend of BNP. Therefore a randomized study has to be 
performed with different post-shock pacing intervals. 
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